Asia-Pacific Americas Africa Europe Middle East

ABDI IBRAHIMI ILAC SAN VE TIC A S

Company Profile:



Company Type: Manufacturer (Factory)

Company Introduction:

Abdi İbrahim İlaç Sanayi ve Ticaret A.Ş. is Turkey's largest and oldest pharmaceutical company, established in 1912. For over a century, it has been a leading player in the pharmaceutical industry, consistently holding the highest market share in Turkey by both sales value and prescription volume.

The company is primarily engaged in the research, development, manufacturing, and marketing of a wide array of pharmaceutical products across various therapeutic areas. These include central nervous system, metabolism, oncology, immunology, and rare diseases, among others. Abdi İbrahim operates modern, state-of-the-art manufacturing facilities in Turkey, which adhere to international Good Manufacturing Practices (GMP) standards.

Abdi İbrahim has a strong commitment to innovation, making significant investments in research and development to bring new and effective treatments to patients. In addition to its dominant position in the domestic market, the company has a growing international presence, exporting its products to numerous countries and having direct operations in several regions. Its mission is to contribute to public health and improve the quality of life through its high-quality and accessible pharmaceutical solutions.

Enterprise Products

Here are some products manufactured or marketed by ABDI IBRAHIM ILAC SAN VE TIC A.S.:

* Pharmaceuticals (various therapeutic areas)

* Vitamins and Supplements

* Dermatological Products

* Medical Devices

Business Registration Information:

Manager:

CEO: Suha Taspolatoglu, Chairman of the Board: Nezih Barut

Phone:

+90 212 371 40 00

E-mail:

Not publicly available for general inquiries. Please use the contact form on their website.

Official Website:
Address:

Sanayi Mahallesi Tunc Caddesi No:3 Esenyurt / Istanbul, Turkey

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.